Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
BMJ Open
|
October 15, 2021
How can rural community-engaged health services planning achieve sustainable healthcare system changes?
Campbell Stuart Johnston, Erika Belanger, Krystal Wong, et al.
Osteoarthritis and Cartilage
|
June 8, 2025
Calcium pyrophosphate deposition disease is associated with increased risk of fractures: A retrospective cohort study using electronic health record data
Sizheng Steven Zhao, Weijie Liu, Stuart Johnston, et al.
Rheumatology Advances in Practice
|
April 14, 2026
Incidence of gout in spondyloarthritis
Stuart Johnston, Benjamin Zuckerman, Aashmi Sharma, et al.
Small Methods
|
December 22, 2022
Capturing and Quantifying Particle Transcytosis with Microphysiological Intestine-on-Chip Models
Ludivine C Delon, Matthew Faria, Zhengyang Jia, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research
|
August 17, 2025
Calcium-dependent regulation of physiological vs pathological cardiomyocyte hypertrophy
Joshua Chung, Nathan Isles, Stuart Johnston, et al.
The International Journal of Artificial Organs
|
October 22, 2010
Rapid identification of staphylococci from prosthetic joint infections using MALDI-TOF mass-spectrometry
Llinos G Harris, Khalid El-Bouri, Stuart Johnston, et al.
Journal of Clinical Microbiology
|
September 21, 2012
Identification of clinical isolates of α-hemolytic streptococci by 16S rRNA gene sequencing, matrix-assisted laser desorption ionization-time of flight mass spectrometry using MALDI Biotyper, and conventional phenotypic methods: a comparison
Angharad Puw Davies, Michelle Reid, Stephen J Hadfield, et al.
Cancer Research
|
November 16, 2011
Intermittent administration of MEK inhibitor GDC-0973 plus PI3K inhibitor GDC-0941 triggers robust apoptosis and tumor growth inhibition
Klaus P Hoeflich, Mark Merchant, Christine Orr, et al.
Investigational New Drugs
|
July 18, 2016
A first-in-human phase I study to evaluate the MEK1/2 inhibitor, cobimetinib, administered daily in patients with advanced solid tumors
Lee S Rosen, Patricia LoRusso, Wen Wee Ma, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Novel Carboxamide-Based Allosteric MEK Inhibitors: Discovery and Optimization Efforts toward XL518 (GDC-0973)
Kenneth D Rice, Naing Aay, Neel K Anand, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
BMJ Open
|
October 15, 2021
How can rural community-engaged health services planning achieve sustainable healthcare system changes?
Campbell Stuart Johnston, Erika Belanger, Krystal Wong, et al.
Osteoarthritis and Cartilage
|
June 8, 2025
Calcium pyrophosphate deposition disease is associated with increased risk of fractures: A retrospective cohort study using electronic health record data
Sizheng Steven Zhao, Weijie Liu, Stuart Johnston, et al.
Rheumatology Advances in Practice
|
April 14, 2026
Incidence of gout in spondyloarthritis
Stuart Johnston, Benjamin Zuckerman, Aashmi Sharma, et al.
Small Methods
|
December 22, 2022
Capturing and Quantifying Particle Transcytosis with Microphysiological Intestine-on-Chip Models
Ludivine C Delon, Matthew Faria, Zhengyang Jia, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research
|
August 17, 2025
Calcium-dependent regulation of physiological vs pathological cardiomyocyte hypertrophy
Joshua Chung, Nathan Isles, Stuart Johnston, et al.
The International Journal of Artificial Organs
|
October 22, 2010
Rapid identification of staphylococci from prosthetic joint infections using MALDI-TOF mass-spectrometry
Llinos G Harris, Khalid El-Bouri, Stuart Johnston, et al.
Journal of Clinical Microbiology
|
September 21, 2012
Identification of clinical isolates of α-hemolytic streptococci by 16S rRNA gene sequencing, matrix-assisted laser desorption ionization-time of flight mass spectrometry using MALDI Biotyper, and conventional phenotypic methods: a comparison
Angharad Puw Davies, Michelle Reid, Stephen J Hadfield, et al.
Cancer Research
|
November 16, 2011
Intermittent administration of MEK inhibitor GDC-0973 plus PI3K inhibitor GDC-0941 triggers robust apoptosis and tumor growth inhibition
Klaus P Hoeflich, Mark Merchant, Christine Orr, et al.
Investigational New Drugs
|
July 18, 2016
A first-in-human phase I study to evaluate the MEK1/2 inhibitor, cobimetinib, administered daily in patients with advanced solid tumors
Lee S Rosen, Patricia LoRusso, Wen Wee Ma, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Novel Carboxamide-Based Allosteric MEK Inhibitors: Discovery and Optimization Efforts toward XL518 (GDC-0973)
Kenneth D Rice, Naing Aay, Neel K Anand, et al.
Page
of 3